Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -5.74 % |
3 Month Return | -21.31 % |
1 Year Return | + 15.41 % |
Market Stats | |
Previous Close | ₹82.00 |
Open | ₹82.00 |
Volume | 815.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹176.80Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹176.80 Cr |
P/B Ratio | -1.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹176.80 Cr | -1.54% | 0.96 | NA | NA | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Krebs Biochemicals & Industries Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries reported a 21.81% increase in topline revenue and a 3.03% decrease in losses year-over-year for Q1. The EPS stands at ₹-2.4, reflecting a 2.83% increase YoY. The company has delivered -5.71% return in the last week, but positive returns of 14.37% over six months and 9.41% YTD.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 181.9%
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 68.3%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.74% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.76% of holdings in Sep 2024 quarter
Price Dip
In the last 3 months, KREBSBIO stock has moved down by -21.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.74% | 0.00 | |
Foreign Institutions | 0.49% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.76% | 0.00 | |
Others | 0.01% | 250.00 |
Krebs Biochemicals & Industries Ltd’s net profit jumped 3% since last year same period to ₹-5.17Cr in the Q1 2024-2025. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated 11.62% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Krebs Biochemicals & Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.
Krebs Biochemicals & Industries Ltd (KREBSBIO) share price today is ₹82
Krebs Biochemicals & Industries Ltd is listed on NSE
Krebs Biochemicals & Industries Ltd is listed on BSE
Today’s traded volume of Krebs Biochemicals & Industries Ltd(KREBSBIO) is 815.00.
Today’s market capitalisation of Krebs Biochemicals & Industries Ltd(KREBSBIO) is ₹176.8Cr.
Krebs Biochemicals & Industries Ltd(KREBSBIO | Price |
---|---|
52 Week High | ₹121.55 |
52 Week Low | ₹60.35 |
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹82. It is down -32.54% from its 52 Week High price of ₹121.55
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹82. It is up 35.87% from its 52 Week Low price of ₹60.35